Dr. Robinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
PO Box 4008
Fort Lauderdale, FL 33338Phone+1 984-710-8215- Is this information wrong?
Summary
- Keith Robinson is Senior Medical Director with the Medical & Scientific Management group of Syneos Health. Keith is a board certified Pulmonary Medicine and Critical Care Medicine physician with over 17 years of clinical experience. Before Syneos, Keith worked as an Intensivist and Pulmonary Medicine Consultant with Pulmonary Physicians of South Florida, LLC, serving as Medical Director of Fusion Health Pulmonary Rehabilitation & Wellness for 7
years. His professional activities include 10 years of clinical research, as a principle investigator, in pneumonia, asthma, COPD, and pulmonary hypertension trials. In addition, Keith has spent 11 years as a consultant and advisor to Astra Zeneca, Mylan, Theravance, Sunovion, Actelion, CAIRE Industries, and AG Industries.
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
- University of Florida College of Medicine JacksonvilleResidency, Internal Medicine, 2000 - 2003
- Florida State UniversityMS, Exercise Physiology, 1995 - 2000
- Indiana University School of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2003 - Present
- FL State Medical License 2002 - 2023
- National Board of Physicians and Surgeons Critical Care Medicine
- National Board of Physicians and Surgeons Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsBronchial Stricture and Hemoptysis in a Woman With Sickle Cell AnemiaKeith J. Robinson, James D. Cury, Luis F. Laos> ;Chest. 2004 Feb 1
- 52 citationsFatal cholestatic liver failure associated with gemcitabine therapy.Keith Robinson, Louis R. Lambiase, Jianjun Li, Carmela Monteiro, Michael Schiff> ;Digestive Diseases and Sciences. 2003 Sep 1
- 22 citationsDendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial.Aaron M Gusdon, Nauder Faraday, John S Aita, Sunil Kumar, Ishan Mehta, HuiMahn A Choi, Jeffery L Cleland, Keith Robinson, Louise D McCullough, Derek K Ng, Rangaramanuj...> ;Science Translational Medicine. 2022 Jul 20
- Join now to see all
Journal Articles
- Exploring the Anti-Hypoxaemia Effect of Hydromethylthionine: A Prospective Study of Phase 3 Clinical Trial ParticipantsMohammad Arastoo, Michael P. Mazanetz, Sonya Miller, Helen Shiells, Claire Hull, Keith Robinson, John M. D. Store, Charles R. Harrington, and Claude M. Wischik, International Journal of Molecular Sciences, 9/6/2023
- Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren'sLee, A., Scofiel, R., Robinson, K., et. al., CHEST, 2/2021
- Initial Usability and Validation of Inspiration Point, a digital Pulmonary Rehabilitation Tool for use with self- management interventions.Flynn, S., Oveido, V., Robinson, K., Journal of Cardiopulmonary Rehabilitation and Prevention, 2018
- Join now to see all
Lectures
- Chronic obstructive pulmonary disease (COPD): better breathing begins in internal medicine
- COPD Readmission Reduction
- IPF New Strategies and Novel Therapies CME
Other
- COVID-19 and the Changing Landscape for Clinical Research: Implications for Ongoing WavesKeith Robinson, Lou Boccumini, Anna Abramenkova, Jaime Hernandez, Susanne Schmidt, Gustavo Quintana, Susan Johnson
https://www.syneoshealth.com/insights-hub/covid-19-and-changing-landscape-clinical-research-implications-ongoing-waves
10/18/2022 - Invasive BIPAP May Delay Mechanical Ventilation in Patients with COVID-19Keith Robinson, MD
http://www.covid-bipapinfo.com
Authored Content
- Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren'sFebruary 2021
Committees
- co- chair, Pulmonary Hypertension
- CAC, COPD Foundation
Industry Relationships
- Research Advisor, Actelion
- COPD advisor, Astra Zeneca
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: